Clinical and Developmental Immunology
Volume 2008 (2008), Article ID 305859, 12 pages
doi:10.1155/2008/305859
Research Article

Comparative Study of Regulatory T Cell Function of Human CD25+CD4+ T Cells from Thymocytes, Cord Blood, and Adult Peripheral Blood

1Division of Clinical Immunology, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan
2Department of Microbiology and Immunology, Tokyo Women's Medical University, Tokyo 162-8666, Japan
3Human Medical Science Division, Kagawa Nutrition University, Saitama 350-0288, Japan
4Department of Cardiovascular Surgery, Tokyo Women's Medical University, Tokyo 162-8666, Japan
5Department of Obstetrics and Gynecology, Yoshida Clinic, Saitama 358-0054, Japan
6Department of Hematologic Malignancies, Nevada Cancer Institute, Las Vegas, NV 89135, USA

Received 13 February 2008; Revised 16 April 2008; Accepted 20 May 2008

Academic Editor: Yasunobu Yoshikai

Copyright © 2008 Wakae Fujimaki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Takahashi, Y. Kuniyasu, M. Toda, et al., “Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state,” International Immunology, vol. 10, no. 12, pp. 1969–1980, 1998. View at Publisher · View at Google Scholar
  2. S. Sakaguchi, “Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses,” Annual Review of Immunology, vol. 22, pp. 531–562, 2004. View at Publisher · View at Google Scholar · View at PubMed
  3. S. Sakaguchi, N. Sakaguchi, J. Shimizu, et al., “Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance,” Immunological Reviews, vol. 182, pp. 18–32, 2001. View at Publisher · View at Google Scholar
  4. V. R. Aluvihare, M. Kallikourdis, and A. G. Betz, “Regulatory T cells mediate maternal tolerance to the fetus,” Nature Immunology, vol. 5, no. 3, pp. 266–271, 2004. View at Publisher · View at Google Scholar · View at PubMed
  5. J. Shimizu, S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi, “Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance,” Nature Immunology, vol. 3, no. 2, pp. 135–142, 2002. View at Publisher · View at Google Scholar · View at PubMed
  6. T. Takahashi, T. Tagami, S. Yamazaki, et al., “Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4,” The Journal of Experimental Medicine, vol. 192, no. 2, pp. 303–309, 2000. View at Publisher · View at Google Scholar
  7. E. M. Shevach and G. L. Stephens, “The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?,” Nature Reviews Immunology, vol. 6, no. 8, pp. 613–618, 2006. View at Publisher · View at Google Scholar · View at PubMed
  8. S. Hori, T. Nomura, and S. Sakaguchi, “Control of regulatory T cell development by the transcription factor Foxp3,” Science, vol. 299, no. 5609, pp. 1057–1061, 2003. View at Publisher · View at Google Scholar · View at PubMed
  9. J. D. Fontenot, M. A. Gavin, and A. Y. Rudensky, “Foxp3 programs the development and function of CD4+CD25+ regulatory T cells,” Nature Immunology, vol. 4, no. 4, pp. 330–336, 2003. View at Publisher · View at Google Scholar · View at PubMed
  10. R. Khattri, T. Cox, S.-A. Yasayko, and F. Ramsdell, “An essential role for Scurfin in CD4+CD25+ T regulatory cells,” Nature Immunology, vol. 4, no. 4, pp. 337–342, 2003. View at Publisher · View at Google Scholar · View at PubMed
  11. Y. Wu, M. Borde, V. Heissmeyer, et al., “FOXP3 controls regulatory T cell function through cooperation with NFAT,” Cell, vol. 126, no. 2, pp. 375–387, 2006. View at Publisher · View at Google Scholar · View at PubMed
  12. H. Yagi, T. Nomura, K. Nakamura, et al., “Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells,” International Immunology, vol. 16, no. 11, pp. 1643–1656, 2004. View at Publisher · View at Google Scholar · View at PubMed
  13. S. J. Bensinger, A. Bandeira, M. S. Jordan, A. J. Caton, and T. M. Laufer, “Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4+25+immunoregulatory T cells,” The Journal of Experimental Medicine, vol. 194, no. 4, pp. 427–438, 2001. View at Publisher · View at Google Scholar
  14. N. Watanabe, Y.-H. Wang, H. K. Lee, et al., “Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus,” Nature, vol. 436, no. 7054, pp. 1181–1185, 2005. View at Publisher · View at Google Scholar · View at PubMed
  15. C. A. Thornton, J. W. Upham, M. E. Wikström, et al., “Functional maturation of CD4+CD25+CTLA4+CD45RA+ T regulatory cells in human neonatal T cell responses to environmental antigens/allergens,” The Journal of Immunology, vol. 173, no. 5, pp. 3084–3092, 2004.
  16. Y. Takahata, A. Nomura, H. Takada, et al., “CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene,” Experimental Hematology, vol. 32, no. 7, pp. 622–629, 2004. View at Publisher · View at Google Scholar · View at PubMed
  17. N. Seddiki, B. Santner-Nanan, S. G. Tangye, et al., “Persistence of naive CD45RA+ regulatory T cells in adult life,” Blood, vol. 107, no. 7, pp. 2830–2838, 2006. View at Publisher · View at Google Scholar · View at PubMed
  18. K. Wing, A. Ekmark, H. Karlsson, A. Rudin, and E. Suri-Payer, “Characterization of human CD25+CD4+ T cells in thymus, cord and adult blood,” Immunology, vol. 106, no. 2, pp. 190–199, 2002. View at Publisher · View at Google Scholar
  19. K. Wing, P. Larsson, K. Sandström, S. B. Lundin, E. Suri-Payer, and A. Rudin, “CD4+CD25+FOXP3+ regulatory T cells from human thymus and cord blood suppress antigen-specific T cell responses,” Immunology, vol. 115, no. 4, pp. 516–525, 2005. View at Publisher · View at Google Scholar · View at PubMed
  20. D. Valmori, A. Merlo, N. E. Souleimanian, C. S. Hesdorffer, and M. Ayyoub, “A peripheral circulating compartment of natural naive CD4+ Tregs,” Journal of Clinical Investigation, vol. 115, no. 7, pp. 1953–1962, 2005. View at Publisher · View at Google Scholar · View at PubMed
  21. N. Takahashi, K. Imanishi, H. Nishida, and T. Uchiyama, “Evidence for immunologic immaturity of cord blood T cells: cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen,” The Journal of Immunology, vol. 155, no. 11, pp. 5213–5219, 1995.
  22. K. Imanishi, K. Seo, H. Kato, et al., “Post-thymic maturation of migrating human thymic single-positive T cells: thymic CD1a-CD4+ T cells are more susceptible to anergy induction by toxic shock syndrome toxin-1 than cord blood CD4+ T cells,” The Journal of Immunology, vol. 160, no. 1, pp. 112–119, 1998.
  23. M. B. Bradley and M. S. Cairo, “Cord blood immunology and stem cell transplantation,” Human Immunology, vol. 66, no. 5, pp. 431–446, 2005. View at Publisher · View at Google Scholar · View at PubMed
  24. N. Takahashi, H. Nishida, H. Kato, K. Imanishi, Y. Sakata, and T. Uchiyama, “Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period,” The Lancet, vol. 351, no. 9116, pp. 1614–1619, 1998. View at Publisher · View at Google Scholar
  25. A. D. Hess, “Modulation of graft-versus-host disease: role of regulatory T lymphocytes,” Biology of Blood and Marrow Transplantation, vol. 12, no. 1, supplement 2, pp. 13–21, 2006. View at Publisher · View at Google Scholar · View at PubMed
  26. P. Hoffmann and M. Edinger, “CD4+CD25+ regulatory T cells and graft-versus-host disease,” Seminars in Hematology, vol. 43, no. 1, pp. 62–69, 2006. View at Publisher · View at Google Scholar · View at PubMed
  27. W. R. Godfrey, D. J. Spoden, Y. G. Ge, et al., “Cord blood CD4+CD25+-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function,” Blood, vol. 105, no. 2, pp. 750–758, 2005. View at Publisher · View at Google Scholar · View at PubMed
  28. F. Fallarino, U. Grohmann, K. W. Hwang, et al., “Modulation of tryptophan catabolism by regulatory T cells,” Nature Immunology, vol. 4, no. 12, pp. 1206–1212, 2003. View at Publisher · View at Google Scholar · View at PubMed
  29. S. Read, V. Malmström, and F. Powrie, “Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation,” The Journal of Experimental Medicine, vol. 192, no. 2, pp. 295–302, 2000. View at Publisher · View at Google Scholar
  30. K. Wing, S. Lindgren, G. Kollberg, et al., “CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cells,” The European Journal of Immunology, vol. 33, no. 3, pp. 579–587, 2003. View at Publisher · View at Google Scholar · View at PubMed
  31. M. Miyara, Z. Amoura, C. Parizot, et al., “Global natural regulatory T cell depletion in active systemic lupus erythematosus,” The Journal of Immunology, vol. 175, no. 12, pp. 8392–8400, 2005.
  32. K. E. Earle, Q. Tang, X. Zhou, et al., “In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation,” Clinical Immunology, vol. 115, no. 1, pp. 3–9, 2005. View at Publisher · View at Google Scholar · View at PubMed
  33. Y. Peng, Y. Laouar, M. O. Li, E. A. Green, and R. A. Flavell, “TGF-β regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 13, pp. 4572–4577, 2004. View at Publisher · View at Google Scholar · View at PubMed
  34. Y. M. D. Lo, E. S. F. Lo, N. Watson, et al., “Two-way cell traffic between mother and fetus: biologic and clinical implications,” Blood, vol. 88, no. 11, pp. 4390–4395, 1996.
  35. M. S. Pollack, D. Kirkpatrick, N. Kapoor, B. Dupont, and R. J. O'Breilly, “Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency,” The New England Journal of Medicine, vol. 307, no. 11, pp. 662–666, 1982.
  36. L. F. Thompson, R. D. O'Connor, and J. F. Bastian, “Phenotype and function of engrafted maternal T cells in patients with severe combined immunodeficiency,” The Journal of Immunology, vol. 133, no. 5, pp. 2513–2517, 1984.
  37. P. Rubinstein, C. Carrier, A. Scaradavou, et al., “Outcomes among 562 recipients of placental-blood transplants from unrelated donors,” The New England Journal of Medicine, vol. 339, no. 22, pp. 1565–1577, 1998. View at Publisher · View at Google Scholar · View at PubMed